New dedicated blunt straight needles and sutures for uterine compression sutures: a retrospective study and literature review.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
11 Mar 2019
Historique:
received: 20 11 2018
accepted: 01 03 2019
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 9 5 2019
Statut: epublish

Résumé

We developed a dedicated blunt straight needle with No. 2 polydioxanone sutures (2-Monodiox®) for uterine compression sutures (UCSs) and aimed to assess the outcomes and complication rates of UCSs for postpartum hemorrhage by comparing with commercially available needle and suture types. A retrospective analysis was performed between January 2010 and February 2018. During the study period, two types of commercially available sutures and 2-Monodiox® were used. PubMed, MEDLINE, and Scopus databases were searched for English articles published between January 1997 and May 2017 using search terms related to the suture and needle types for UCSs to discuss the dedicated needles and sutures for UCS. The analysis included 47 cases of UCSs for the uterine body with three suture types (No. 0 polydioxanone, 7 cases; No. 1 poliglecaprone 25, 21 cases; and No. 2 polydioxanone, 19 cases). B-Lynch suture using No. 0 sutures was associated with a significantly lower uterine preservation rate than those with Nos. 1 and 2 sutures (42.9% vs. 95.2 and 89.5%, respectively; p < 0.01). A modified Hayman suture technique was performed using 2-Monodiox® sutures, which achieved a similar uterine preservation rate compared with B-Lynch suture using No. 1 poliglecaprone 25 sutures. No patients developed severe complications. The literature review showed that no dedicated sutures have developed for UCSs. Three dedicated needles for UCSs have been developed, and 2-Monodiox® is the first dedicated blunt straight needle for UCSs. Our data showed that No. 0 sutures should not be used for B-Lynch suture. The uterine preservation rate is similar for 2-Monodiox® with modified Hayman suture and No. 1 poliglecaprone 25 sutures with B-Lynch suture, without the occurrence of severe complications.

Sections du résumé

BACKGROUND BACKGROUND
We developed a dedicated blunt straight needle with No. 2 polydioxanone sutures (2-Monodiox®) for uterine compression sutures (UCSs) and aimed to assess the outcomes and complication rates of UCSs for postpartum hemorrhage by comparing with commercially available needle and suture types.
METHODS METHODS
A retrospective analysis was performed between January 2010 and February 2018. During the study period, two types of commercially available sutures and 2-Monodiox® were used. PubMed, MEDLINE, and Scopus databases were searched for English articles published between January 1997 and May 2017 using search terms related to the suture and needle types for UCSs to discuss the dedicated needles and sutures for UCS.
RESULTS RESULTS
The analysis included 47 cases of UCSs for the uterine body with three suture types (No. 0 polydioxanone, 7 cases; No. 1 poliglecaprone 25, 21 cases; and No. 2 polydioxanone, 19 cases). B-Lynch suture using No. 0 sutures was associated with a significantly lower uterine preservation rate than those with Nos. 1 and 2 sutures (42.9% vs. 95.2 and 89.5%, respectively; p < 0.01). A modified Hayman suture technique was performed using 2-Monodiox® sutures, which achieved a similar uterine preservation rate compared with B-Lynch suture using No. 1 poliglecaprone 25 sutures. No patients developed severe complications. The literature review showed that no dedicated sutures have developed for UCSs. Three dedicated needles for UCSs have been developed, and 2-Monodiox® is the first dedicated blunt straight needle for UCSs.
CONCLUSION CONCLUSIONS
Our data showed that No. 0 sutures should not be used for B-Lynch suture. The uterine preservation rate is similar for 2-Monodiox® with modified Hayman suture and No. 1 poliglecaprone 25 sutures with B-Lynch suture, without the occurrence of severe complications.

Identifiants

pubmed: 30866898
doi: 10.1186/s12893-019-0495-7
pii: 10.1186/s12893-019-0495-7
pmc: PMC6417176
doi:

Substances chimiques

Polydioxanone 31621-87-1

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan
ID : 17K11278

Références

Obstet Gynecol. 2000 Jul;96(1):129-131
pubmed: 10928901
Obstet Gynecol. 2002 Mar;99(3):502-6
pubmed: 11864681
Int J Fertil Womens Med. 2005 Jul-Aug;50(4):148-63
pubmed: 16405100
BJOG. 2006 Nov;113(11):1341; author reply 1342
pubmed: 17059399
World J Emerg Surg. 2009 Nov 25;4:43
pubmed: 19939251
Acta Obstet Gynecol Scand. 2012 Jan;91(1):147-51
pubmed: 21501126
Taiwan J Obstet Gynecol. 2011 Jun;50(2):179-81
pubmed: 21791304
Acta Obstet Gynecol Scand. 2013 Apr;92(4):378-85
pubmed: 23330882
Aust N Z J Obstet Gynaecol. 2013 Feb;53(1):94-7
pubmed: 23405999
Acta Obstet Gynecol Scand. 2013 Aug;92(8):988-9
pubmed: 23550567
J Obstet Gynaecol Res. 2014 Feb;40(2):387-91
pubmed: 24118407
J Med Assoc Thai. 2013 Nov;96(11):1408-15
pubmed: 24428089
Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):283-6
pubmed: 24506478
BJOG. 2015 Feb;122(3):429-33
pubmed: 25175111
Int J Gynaecol Obstet. 2014 Nov;127(2):180-2
pubmed: 25277790
Arch Gynecol Obstet. 2015 Feb;291(2):305-10
pubmed: 25288270
Gynecol Obstet Invest. 2015;80(4):228-33
pubmed: 25766082
J Obstet Gynaecol Res. 2015 Jun;41(6):993-4
pubmed: 25873279
Clin Exp Obstet Gynecol. 2015;42(2):202-7
pubmed: 26054120
Taiwan J Obstet Gynecol. 2016 Apr;55(2):193-7
pubmed: 27125401
Clin Exp Obstet Gynecol. 2016;43(3):434-6
pubmed: 27328508
J Obstet Gynaecol Res. 2016 Nov;42(11):1627-1628
pubmed: 27527990
BMC Pregnancy Childbirth. 2016 Aug 27;16:251
pubmed: 27567670
Int J Gynaecol Obstet. 2017 Apr;137(1):1-7
pubmed: 28099749
BMC Pregnancy Childbirth. 2017 May 31;17(1):160
pubmed: 28569213
Int J Gynaecol Obstet. 2017 Oct;139(1):28-33
pubmed: 28661579
Obstet Gynecol. 2017 Oct;130(4):e168-e186
pubmed: 28937571
Arch Gynecol Obstet. 2019 Jan;299(1):113-121
pubmed: 30357496
Br J Obstet Gynaecol. 1997 Mar;104(3):372-5
pubmed: 9091019

Auteurs

Shinya Matsuzaki (S)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. zacky@gyne.med.osaka-u.ac.jp.

Masayuki Endo (M)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Takuji Tomimatsu (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Satoshi Nakagawa (S)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Satoko Matsuzaki (S)

Department of Obstetrics and Gynecology, Otemae Hospital, 1-5-34, Otemae, Tyuuouku, Osaka, 540-0008, Japan.

Tatsuya Miyake (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Tsuyoshi Takiuchi (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Aiko Kakigano (A)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Kazuya Mimura (K)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Yutaka Ueda (Y)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Tadashi Kimura (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH